Skip to content

Use of small implantable ECG recorder in women with peripartum cardiomyopathy

Use of small implantable ECG recorder in women with peripartum cardiomyopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202104866174807
Enrollment
20
Registered
2021-04-14
Start date
2017-05-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System

Interventions

24h Holter Monitoring
Implantable Loop recorder

Sponsors

Medtronic
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: - Patients with a confirmed diagnosis of PPCM - Age greater than 18 years - Patients willing and able to give informed consent - Patient is able (in the investigators’ opinion) to comply with all study requirements and return for follow-up

Exclusion criteria

Exclusion criteria: - Patients who are unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Determine the burden of arrhythmias occurring in PPCM by means of ambulatory ECG monitoring by 24h Holter and ILR

Secondary

MeasureTime frame
1. To document incidence of life-threatening arrhythmias as detected by Holter monitoring versus implantable loop recorder (amongst those with an LVEF = 35% vs > 35%). 2. To document atrial tachyarrhythmia’s (atrial fibrillation, atrial flutter) to identify potential candidates for anticoagulation. 3. To determine average heart rate and the burden of sinus tachycardia on Holter monitoring (amongst those with an LVEF = 35% vs > 35%).

Countries

South Africa

Contacts

Public ContactOlivia Briton

Research Nurse Cape Heart Institute

olivia.briton@uct.ac.za+27214066358

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026